SCHEMBL3848425

SCHEMBL3848425

CN(C)S(=O)(=O)N1CCN(c2ncnc3ccc(-c4cn[nH]c4)cc23)CC1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ENPP1 P22413 2/20 0.52
AKT1 P31749 1/20 0.52
CYP3A4 P08684 13/20 0.49
CYP1A2 P05177 12/20 0.49
CYP2D6 P10635 7/20 0.49
CYP2C19 P33261 5/20 0.49
KDM4E B2RXH2 3/20 0.49
HPGD P15428 2/20 0.49
MAPT P10636 1/20 0.49
CLK4 Q9HAZ1 12/20 0.48
HIF1A Q16665 7/20 0.48
USP2 O75604 7/20 0.48
HSD17B10 Q99714 4/20 0.48
TSHR P16473 3/20 0.48
LMNA P02545 8/20 0.46
MAPK1 P28482 7/20 0.46
ALDH1A1 P00352 7/20 0.46
MEN1 O00255 4/20 0.46
KMT2A Q03164 4/20 0.46
ALOX15 P16050 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4760756 0.85 AKT1 (0.49) ENPP1AKT1CYP3A4CYP1A2CYP2D6
SCHEMBL3854869 0.83 GBA1 (0.62) ENPP1AKT1CYP3A4CYP1A2CYP2D6
SCHEMBL13874369 0.83 AKT1 (0.48) ENPP1AKT1CYP3A4CYP1A2CYP2D6
SCHEMBL3850109 0.83 CYP3A4 (0.65) AKT1CYP3A4CYP1A2CYP2D6CYP2C19
SCHEMBL3867694 0.80 AKT1 (0.58) ENPP1AKT1CYP3A4CYP1A2CYP2D6
SCHEMBL4716295 0.79 CYP1A2 (0.50) ENPP1AKT1CYP3A4CYP1A2CYP2D6
SCHEMBL3849267 0.79 AKT1 (0.49) ENPP1AKT1CYP3A4CYP1A2CYP2D6
SCHEMBL3849360 0.79 CYP3A4 (0.46) ENPP1CYP3A4CYP1A2CYP2D6CYP2C19
Hydrochloric Acid SCHEMBL3850750 0.78 AKT1 (0.49) ENPP1AKT1CYP3A4CYP1A2CYP2D6
Hydrochloric Acid SCHEMBL3851639 0.78 ACHE (0.54) AKT1CYP3A4CYP1A2CYP2D6CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP disclosed
US-7074801-B1 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof EISAI CO., LTD. (JP) 2006-07-11 US disclosed
EP-1382603-A1 NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF Eisai Co., Ltd. (JP) 2004-01-21 EP disclosed